Primary sclerosing cholangitis: Emerging new promising therapies

Journal of Clinical Gastroenterology

Volumn 31, Issue 4, 2000, Pages 271-273

  Angulo, P ^a   Lindor, K D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBROTIC AGENT; ANTIOXIDANT; AZATHIOPRINE; BUDESONIDE; COLCHICINE; CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; NICOTINE; PENICILLAMINE; PENTOXIFYLLINE; PREDNISONE; TACROLIMUS; URSODEOXYCHOLIC ACID;

CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; DRUG MEGADOSE; GENETIC PREDISPOSITION; HUMAN; IMMUNE COMPLEX DISEASE; MONOTHERAPY; PATHOGENESIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; REVIEW;

CHOLANGITIS, SCLEROSING; HUMANS;

EID: 0033658805     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200012000-00001     Document Type: Review

References (29)

1. Patients with asymptomatic primary sclerosing cholangitis frequently have progressive disease
2. Primary sclerosing cholangitis
3. Primary sclerosing cholangitis
4. An open-label pilot trial of cladibrine (2-CdA) in patients with primary sclerosing cholangitis
5. Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: A 30-month pilot study
6. Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: A placebo-controlled trial
7. Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period
8. Ursodeoxycholic acid does not improve the clinical course of primary sclerosing cholangitis over 2-year period
9. Ursodiol for primary sclerosing cholangitis
10. High dose ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis (PSC): Results after two years of a randomized, double-blind, placebo-controlled trial
11. High dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis
12. Colchicine treatment of primary sclerosing cholangitis
13. A controlled clinical trial evaluating cyclosporine in the treatment of primary sclerosing cholangitis
14. A double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis
15. Prospective trial of penicillamine in primary sclerosing cholangitis
16. Tacrolimus (FK506), a treatment of primary sclerosing cholangitis: Results of an open-label preliminary trial
17. Positive corticosteroid response in early primary sclerosing cholangitis
18. Primary sclerosing cholangitis. Complete gross and histologic reversal after long-term steroid therapy
19. Oral budesonide in the treatment of patients with primary sclerosing cholangitis
20. Azathioprine in primary sclerosing cholangitis
21. Azathioprine treatment in primary sclerosing cholangitis
22. Oral nicotine in treatment of primary sclerosing cholangitis: A pilot study
23. A pilot study evaluating pentoxifylline in the treatment of primary sclerosing cholangitis
24. Oral pirfenidone in the treatment of patients with primary sclerosing cholangitis
25. Ursodeoxycholic acid and methotrexate for primary sclerosing cholangitis: A pilot study
26. The combination of prednisone and colchicine in patients with primary sclerosing cholangitis
27. Combined therapy with azathioprine, prednisone and ursodiol in patients with primary sclerosing cholangitis. A case series
28. Hepatic inflammation in rats with experimental bacterial overgrowth
29. Role of tumor necrosis factor in causing hepatobiliary injury in rats with experimental small bowel bacterial overgrowth